Jason V. Coloma, CEO: Maze Therapeutics MAZE Sell · Filed 06/24

Trade details

Type: Insider sale
Amount: $621,683.25
Shares · price: 23,865 sh · $26.05 a share
Held after: 319,079 sh
Stock: Maze Therapeutics MAZE
Person: Jason V. ColomaCEO
Trade date: 26/06/23
Filed: 26/06/24
Days to filing: 1 days

Sold 7.0% of holdings

Share of holding sold: 7.0%

Maze Therapeutics trades, last 26 weeks

What else happened in Maze Therapeutics around then

Filed or reported within 30 days of the trade day · 05/24~07/23

Jason V. Coloma's recent trades

Jason V. ColomaCEO
Planned saleMaze Therapeutics
Planned sale
Maze Therapeutics
MAZE
$623.4K
23,497 sh
$623.4K
Filed 09/02
Traded 09/02
Jason V. ColomaCEO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$908.1K
34,501 sh
$908.1K
Filed 09/01
Traded 09/01
Jason V. ColomaCEO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$922.6K
34,501 sh
$922.6K
Filed 08/03
Traded 08/03
Jason V. ColomaCEO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$1M
34,501 sh
$1M
Filed 07/01
Traded 07/01
Jason V. ColomaCEO
Sell10b5-1 planMaze Therapeutics
Sell10b5-1 plan
Maze Therapeutics
MAZE
$53K
2,040 sh
$53K
Filed 06/24
Traded 06/22

Jason V. Coloma, CEO — sold $621.7K of Maze Therapeutics MAZE · 7.0% of holdings · 10b5-1 plan | Whalegun